Mechanistic insights into curcumin’s role in modulating autophagy and redox imbalance in experimentally induced MASH

Background: Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by steatosis, inflammation, and fibrosis. Currently, no approved pharmacological treatment exists. Curcumin has shown potential therapeutic benefits, but its underlying mechanisms remain poorly understood.Aim: This...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of Taibah University for Science Ročník 19; číslo 1
Hlavní autori: Elkordy, Eman A., Zakaria, Soha S., AlHussaini, Khalid I., Sarhan, Naglaa I.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Taylor & Francis Group 31.12.2025
Predmet:
ISSN:1658-3655, 1658-3655
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Background: Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by steatosis, inflammation, and fibrosis. Currently, no approved pharmacological treatment exists. Curcumin has shown potential therapeutic benefits, but its underlying mechanisms remain poorly understood.Aim: This study evaluates curcumin’s role in ameliorating MASH in a high-fat diet (HFD)-induced rat model, focusing on endoplasmic reticulum (ER) stress, apoptosis, autophagy, and oxidative stress. Histological changes were also evaluated.Methods: Male rats were divided into control, MASH, and curcumin-treated MASH groups. Serum and hepatic biomarkers were analyzed including CCAAT/enhancer-binding protein homologous protein (CHOP), Bax, Bcl-2, and Beclin 1. Liver tissues were examined histologically.Results: Curcumin significantly downregulated protein kinase RNA-like endoplasmic reticulum kinase (PERK) and CHOP expression, restored Beclin-1 levels, reduced oxidative stress, and improved Bax/Bcl-2 ratios. Histological analysis confirmed reduced steatosis, and fibrosis.Conclusion: Curcumin alleviates MASH by modulating ER stress, oxidative stress, apoptosis, and autophagy, highlighting its therapeutic potential. Further clinical studies are needed.
ISSN:1658-3655
1658-3655
DOI:10.1080/16583655.2025.2467479